These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16034335)

  • 1. [Conservative treatment of lower limb chronic obliterative atherosclerosis: strategy and tactics].
    Koshkin VM; Stoĭko IuM
    Angiol Sosud Khir; 2005; 11(1):132-5. PubMed ID: 16034335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative care of microcirculatory vessels in patients with lower limb arteriosclerosis obliterans].
    Kuznetsov MR; Koshkin VM; Karalkin AV; Boldin BV; Rodionov SV; Sergeeva NA; Petukhov EB; Golosnitskiĭ PIu
    Angiol Sosud Khir; 2005; 11(1):19-24. PubMed ID: 16034319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiplatelet therapy in patients with chronic obliterating diseases of lower-limb arteries].
    Kuznetsov MR; Tepliakov SA; Sizarev AV; Tugdumov BV; Dzhalilova NS
    Angiol Sosud Khir; 2010; 16(1):43-7. PubMed ID: 20635715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of a new pentoxifilline form-vasonit retard in the treatment of patients with obliterating diseases of the lower limbs arteries].
    Koshkin VM
    Ter Arkh; 2005; 77(4):83-4. PubMed ID: 15938541
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of pentoxifylline and of bio-electromagnetic therapy in lower limb obliterative arterial disease].
    Bernát SI
    Orv Hetil; 2013 Oct; 154(42):1674-9. PubMed ID: 24121220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioxidant and metabolic therapy of lower limb chronic obliterative arterial disease].
    Koshkin VM; Murav'ev SV; Dadova LV; Kalashov PB
    Angiol Sosud Khir; 2006; 12(3):29-32. PubMed ID: 17641611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary prevention and conservative therapy of obliterative arteriosclerosis].
    Landi A
    Orv Hetil; 2004 May; 145(20):1035-43. PubMed ID: 15202325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.
    Ueno M; Ferreiro JL; Tomasello SD; Tello-Montoliu A; Capodanno D; Seecheran N; Kodali M; Dharmashankar K; Desai B; Charlton RK; Bass TA; Angiolillo DJ
    JACC Cardiovasc Interv; 2011 Aug; 4(8):905-12. PubMed ID: 21851906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of therapy with clopidogrel on walking tolerance and parameters of hemostasis in patients with atherosclerosis of lower extremities and intermittent claudication].
    Komarov AL; Kropacheva ES; Tarasova TN; Dobrovol'skiĭ AB; Titaeva EV; Mironova IY; Naumov VG; Panchenko EP
    Kardiologiia; 2002; 42(3):45-50. PubMed ID: 12494186
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of ticlopidine and nifedipine on platelet aggregation in patients with obliterating arteriopathy of the lower limbs].
    Hevia Alonso A; Gago Angelino J; López-Valpuesta FJ; Serrano Molina JS; Fernández-Sanz S
    Rev Clin Esp; 1992 Apr; 190(6):295-8. PubMed ID: 1598427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy in critical limb ischemia: update on clopidogrel and cilostazol.
    Spiliopoulos S
    J Cardiovasc Surg (Torino); 2014 Oct; 55(5):631-40. PubMed ID: 24866775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The CLASSICS Study: Clopidogrel plus ASA vs. Ticlopidin plus ASA in stent-patients].
    Z Kardiol; 1999 May; 88(5 Suppl):1-4. PubMed ID: 10399252
    [No Abstract]   [Full Text] [Related]  

  • 13. Stroke prevention: antiplatelet and antithrombolytic therapy.
    Diener HC
    Haemostasis; 2000; 30 Suppl 3():14-26. PubMed ID: 11182625
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of patients with intermittent claudication.
    Olin JW
    Int J Clin Pract; 2002 Nov; 56(9):687-93. PubMed ID: 12469984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical trial of using antiplatelet therapy to prevent restenosis following peripheral artery angioplasty and stenting].
    Tan JY; Shi WH; He J; Zhu L; Wang TP; Yu B
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):812-5. PubMed ID: 18756983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction.
    Chua D; Lo C; Babor EM
    N Engl J Med; 2005 Jun; 352(25):2647-8; author reply 2647-8. PubMed ID: 15972875
    [No Abstract]   [Full Text] [Related]  

  • 17. Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
    Wang J; Zhu YQ; Li MH; Zhao JG; Tan HQ; Wang JB; Liu F; Cheng YS
    J Vasc Interv Radiol; 2011 Jul; 22(7):987-94. PubMed ID: 21570870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
    Apollonio A; Castignani P; Magrini L; Angeletti R
    J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimal antiplatelet and antithrombotic therapy in patients with ST elevation myocardial infarction].
    Koziński M; Grześk G; Kubica J
    Kardiol Pol; 2012; 70(2):206-12. PubMed ID: 22427098
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M; Albiani B; Ricci M; Russo F
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.